Aberrant overactivation of the Nrf-2 pathway increases cancer cell proliferation by metabolic reprogramming, inhibition of cancer cell apoptosis, and augmentation of cancer stem cell self-renewal potential, indicating a bad prognosis [107]. This evidence concerns the gene NFE2L2 and cancer.